KRISTEN LEANY: Open Payments
NPI 1396238630 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 41 payments from 8 companies in 2025. Trend: 2023 $724 · 2024 $900 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $300 |
| PFIZER INC. | 12 | $155 |
| Amgen Inc. | 7 | $130 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Boston Scientific Corporation | 3 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $37 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
Products named: CAMZYOS, ELIQUIS, REPATHA, LEQVIO, FUROSCIX, AMVUTTRA, VYNDAQEL, OPSUMIT.
Industry payments across UT — which companies pay providers there.
